Table of contents

Extended reports

• Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis (17 August, 2005)

  J J Haringman, T J M Smeets, P Reinders-Blankert, P P Tak
• Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3 (3 August, 2005)

  P Sarzi-Puttini, F Atzeni, J Schölmerich, M Cutolo, R H Straub
• Thermal signature analysis as a novel method for evaluating inflammatory arthritis activity (8 September, 2005)

  M Brenner, C Braun, M Oster, P S Gulko
• Familial hypercholesterolaemia commonly presents with Achilles tenosynovitis (21 September, 2005)

  D Beeharry, B Coupe, E W Benbow, J Morgan, S Kwok, V Charlton-Menys, M France, P N Durrington
• First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis (11 August, 2005)

  J Braun, J Davis, M Dougados, J Sieper, S van der Linden, D van der Heijde
• Synovial Chlamydia trachomatis up regulates expression of a panel of genes similar to that transcribed by Mycobacterium tuberculosis during persistent infection

  (28 September, 2005) Free

  H C Gérard, J A Whittum-Hudson, H R Schumacher, A P Hudson
• Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial (3 August, 2005)

  D van der Heijde, L Klareskog, A Singh, J Tornero, J Melo-Gomes, C Codreanu, R Pedersen, B Freundlich, S Fatenejad
• Orthopaedic surgery of the lower limbs in 49 802 rheumatoid arthritis patients: results from the Swedish National Inpatient Registry during 1987 to 2001 (3 August, 2005)

  R J Weiss, A Stark, M C Wick, A Ehlin, K Palmblad, P Wretenberg
• The shared epitope is a marker of severity associated with selection for, but not with response to, infliximab in a large rheumatoid arthritis population (11 August, 2005)

  H Marotte, B Pallot-Prades, L Grange, J Tebib, P Gaudin, C Alexandre, J L Blond, M A Cazalis, B Mougin, P Miossec
• Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome (3 August, 2005)

  K M J Douglas, A V Pace, G J Treharne, A Saratzis, P Nightingale, N Erb, M J Banks, G D Kitas
• Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis. The ECHODIAH Cohort (1 December, 2005)

  B Mazières, P Garnero, A Guéguen, M Abbal, L Berdah, M Lequesne, M Nguyen, J-P Salles, E Vignon, M Dougados
• Urinary CTX-II levels are associated with radiographic subtypes of osteoarthritis in hip, knee, hand, and facet joints in subject with familial osteoarthritis at multiple sites: the GARP study (3 August, 2005)

  I Meulenbelt, M Kloppenburg, H M Kroon, J J Houwing-Duistermaat, P Garnero, M-P Hellio Le Graverand, J DeGroot, P E Slagboom
• Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles (13 July, 2005)

  S P Linn-Rasker, A H M van der Helm-van Mil, F A van Gaalen, M Kloppenburg, R R P de Vries, S le Cessie, F C Breedveld, R E M Toes, T W J Huizinga
• Aberrant TNF secretion by whole blood in healthy subjects with a history of reactive arthritis: time course in adherent and non-adherent cultures (17 August, 2005)

  K Anttonen, A Orpana, M Leirisalo-Repo, H Repo
• Long term safety of etanercept in elderly subjects with rheumatic diseases (8 September, 2005)

  R Fleischmann, S W Baumgartner, M H Weisman, T Liu, B White, P Peloso
• Antimalarial myopathy: an underdiagnosed complication? Prospective longitudinal study of 119 patients (11 August, 2005)

  E Casado, J Gratacós, C Tolosa, J M Martínez, I Ojanguren, A Ariza, J Real, A Sanjuán, M Larrosa